Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Merck & Co. patents new GTPase KRAS inhibitors

June 17, 2022

Peptide-based radiopharmaceutical with reduced kidney and healthy tissue uptake

June 17, 2022

Aqemia and Sanofi extend collaboration to use AI technology to optimize molecules to treat cancer

June 16, 2022

Dunad Therapeutics and collaborators present new GTPase KRAS inhibitors

June 16, 2022

Beijing Jacobio Pharmaceuticals identifies new GTPase KRAS inhibitors

June 15, 2022

Deciphera Pharmaceuticals discloses PERK and/or GCN2 inhibitors

June 15, 2022

Hamlet and Neurochase partner to develop novel technology to deliver Alpha-1H for CNS tumors

June 14, 2022

NXP-900 shows tumor growth inhibition and survival benefit in mouse model of group 4 medulloblastoma

June 14, 2022

Fochon Pharmaceuticals identifies new BTK inhibitors

June 14, 2022

Qilu Regor Therapeutics presents new STING antagonists

June 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...